Non-Small Cell Lung Cancer Manufacturers, Suppliers & Companies
-
Samyang succeeded in localizing fine materials by producing ion exchange resins in Korea for the first time through a technical partnership with Japan's Mitsubishi Chemical in 1976. Samyang Fine Technology is a joint venture established and invested ...
Pemed - Model S - Injection
Used to treat pleural mesothelioma and non-small-cell lung ...
CONTACT SUPPLIER -
Manufacturerbased in Carlsbad, CALIFORNIA (USA)
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...
Model VAC2 - Immuno-Oncology for Non-Small Cell Lung Cancer (NSCLC)
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous ...
CONTACT SUPPLIER -
Manufacturerbased in Seoul, SOUTH KOREA
Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...
Eutilex - Model EU307(GPC3-IL18) - Hepatocellular Carcinoma and Non-Small Cell Lung Cancer
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller ...
CONTACT SUPPLIER -
Manufacturerbased in Providence, RHODE ISLAND (USA)
Ocean Biomedical is a 21st century biopharma company that partners with leading scientists and research institutions to accelerate the translation of new discoveries into breakthrough medicines. We're working to bring together the interdisciplinary ...
Therapeutic Antibodies for Effective Treatment of Non-Small Cell Lung Cancer
, the tumor suppressor PTEN, and p53. In addition, OCX-253 is a master stimulator of immune checkpoint inhibitor pathways. and plays a critical role in the pathogenesis of primary and metastatic lung cancer. Other ...
CONTACT SUPPLIER -
Manufacturerbased in Morrisville, NORTH CAROLINA (USA)
NightHawk Biosciences is a commercial stage company with a fully integrated ecosystem focused on accelerating the discovery and development of novel medical countermeasures to defend against emerging biothreats. ...
Heat Biologics - Model HS-110 - Biologic Program
HS-110 (viagenpumatucel-L), an Off-the-Shelf Allogeneic Cell Therapy Designed to Stimulate Immune Responses Against Non-Small Cell Lung Cancer ...
CONTACT SUPPLIER -
Manufacturerbased in Shanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
Henlius HANBEITAI - Bevacizumab Injection
HANBEITAI (bevacizumab injection) was approved by the NMPA in November 2021. It is indicated for metastatic colorectal cancer (mCRC), advanced, metastatic or recurrent non-small ...
CONTACT SUPPLIER -
Manufacturerbased in Malvern, PENNSYLVANIA (USA)
We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. We leverage our expertise in superoxide dismutase ...
Aiming to Increase Efficacy of Radiation Therapy
Harnessing the Anticancer Power of Hydrogen Peroxide: As cancer cells are more susceptible than normal cells to increased levels of hydrogen peroxide, we believe the conversion of ...
CONTACT SUPPLIER -
Manufacturerbased in West Chester, PENNSYLVANIA (USA)
MTTI is a Clinical Stage Company; Transforming the lives of patients burdened with severe and life-threatening diseases. Advancing selective radiotherapeutics, EBTATE targeting neuroendocrine tumors, EBRGD for non-small cell lung cancer and ...
-
Technologybased in South San Francisco, CALIFORNIA (USA)
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next-generation cancer therapeutics – antibody drug conjugates, bispecific ...
-
Manufacturerbased in Cambridge, MASSACHUSETTS (USA)
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer. Leveraging decades of industry learnings, we have developed proprietary and highly ...
Upifitamab Rilsodotin (UpRi)
UpRi, a first-in-class ADC targeting the sodium-dependent phosphate transport protein NaPi2b, utilizes the Dolaflexin platform to deliver about 10 DolaLock payload molecules per antibody. The NaPi2b antigen is broadly expressed in ovarian ...
CONTACT SUPPLIER -
Manufacturerbased in Beverly, MASSACHUSETTS (USA)
Cellanyx is a growth stage emerging biotech advancing proprietary phenotypic (appearance and dynamics) biomarker tests based on Machine Vision and AI-driven analysis of live single tumor cells to improve risk-stratification and shared clinical ...
Cellanyx - Breast Cancer LDT Test
Risk stratification of early-stage breast cancer is an active area of research and several commercially available products that are based on genotypic classification. A vexing issue in breast cancer is carcinoma in ...
CONTACT SUPPLIER -
Manufacturerbased in Daejeon, SOUTH KOREA
PANAGENE have been supplying Peptide Nucleic Acid (PNA) worldwide and exclusively since 2006 based on our unique invention of efficient synthesis of PNA with high purity, and nowadays we are possessing the best knowledge on PNA and the largest ...
PANAMutyper - Model EML4-ALK - Screening Kit
PANAMutyper™ EML4-ALK Screening Kit is the qualitative diagnostic test kit which is able to detect 16 different EML4-ALK fusion genes of tissue from non-small cell lung ...
CONTACT SUPPLIER -
Manufacturerbased in Woodcliff Lake, NEW JERSEY (USA)
Eagle is a specialty pharmaceutical company working to advance safe and efficient injectable treatments for patients across oncology, critical care, and orphan diseases. At Eagle, we are committed to developing innovative drugs that result in ...
Pemfexy - Pemetrexed Injection
Indication: PEMFEXY is indicated in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous non-small cell ...
CONTACT SUPPLIER -
Technologybased in Newtown, PENNSYLVANIA (USA)
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways ...
-
Manufacturerbased in Xiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
AmoyDx - Multi-Gene Mutations Detection Kit
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung ...
CONTACT SUPPLIER -
Software vendorbased in Lund, SWEDEN
Our mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. We do this by providing powerful visualization-based bioinformatics data analysis tools for ...
-
Manufacturerbased in Durham, NORTH CAROLINA (USA)
GeneCentric Therapeutics is applying our proprietary rT(I)ME Explorer Platform to identify high resolution molecular subtypes and drug responder populations that enable the development of precision cancer drugs while improving patient outcomes. Our ...
GeneCentric - Lung Cancer Profilers (LSP)
GeneCentric has developed two gene expression profilers (LSP 210 and LSP 220) that define molecular subtypes of the two most common forms of non-small cell lung ...
CONTACT SUPPLIER -
Manufacturerbased in Sherman Oaks, CALIFORNIA (USA)
T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high ...
T-Cure - Model 820TCR - Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1)
The Kita-Kyushu Lung Cancer antigen-1 (KK-LC-1) is a cancer/testis antigen (CTA) that is expressed in multiple solid tumors while restricted to germ line cells in normal tissues. ...
CONTACT SUPPLIER -
Manufacturerbased in Notting Hill, AUSTRALIA
INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes ...
Inoviq - Model EXO-NET RUO - Pan-Exosome Capture Tool
acids, proteins and/or lipids can indicate the presence of a range of cancers, including pancreatic cancer, colorectal cancer [2], breast cancer [3], and ...
CONTACT SUPPLIER -
Manufacturerbased in Emeryville, CALIFORNIA (USA)
Gritstone is developing targeted immunotherapies for cancer and infectious disease. Gritstone’s approach seeks to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells ...
Slate - Shared Neoantigen Immunotherapy
of a Phase I/2 clinical study in combination with checkpoint inhibitors for the treatment of non-small cell lung cancer in patients with relevant KRAS mutations ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you